Communication, FDA and Mayo Clinic - Pharmacy Technician Pulse

Industry group says FDA botched COVID-19 convalescent plasma guidance

pharmaphorum

AUGUST 27, 2020

Already under fire for what some view as a premature authorisation of convalescent plasma for COVID-19, the FDA is now being accused of a blunder that could render current supplies unusable. The post Industry group says FDA botched COVID-19 convalescent plasma guidance appeared first on.

FDA

FDA Mayo Clinic Labelling Communication

Imodium interactions to avoid

The Checkup by Singlecare

NOVEMBER 11, 2023

Imodium carries a warning from the Food and Drug Administration ( FDA ) regarding an association between high doses and cases of sudden cardiac death. Communication is the second necessary precaution. Keep a list of prescription drugs , over-the-counter drugs, and supplements.

Mayo Clinic

Mayo Clinic Communication FDA Compounding

Citalopram interactions to avoid

The Checkup by Singlecare

JANUARY 30, 2024

These communication efforts can make all the difference. Likewise, if you are considering taking a new OTC product or are prescribed a new medicine by a specialist, check in with your primary care provider to ensure no interaction exists.

Mayo Clinic

Mayo Clinic Labelling Adverse Reactions Communication

Hydroxyzine interactions to avoid

The Checkup by Singlecare

OCTOBER 3, 2023

How to minimize hydroxyzine interactions Awareness and communication are your biggest allies in staying safe during medical treatment. Just because they are found in nature does not mean that herbs cannot harm you or interact with drugs like hydroxyzine. Your interest and inquisitions will be welcomed, and as a result, you will be safer.

Mayo Clinic

Mayo Clinic Labelling Communication FDA

Methylprednisolone interactions to avoid

The Checkup by Singlecare

OCTOBER 6, 2023

The interaction is severe enough that prescribing information for many NSAIDs warns against the concomitant use of corticosteroids in a Food and Drug Administration (FDA) issued Medication Guide. Still, they are independently associated with many significant side effects, much so that the FDA has issued guidance regarding their use.

Vaccines

Vaccines Mayo Clinic FDA Immunization

Nitrofurantoin interactions to avoid

The Checkup by Singlecare

SEPTEMBER 27, 2023

However, sulfinpyrazone has been discontinued by the Food and Drug Administration (FDA). When to talk to a healthcare provider about nitrofurantoin interactions In addition to giving your doctor a list of your medications and medical conditions, be sure to communicate openly with your providers about any adverse effects you’re experiencing.

Vaccines

Vaccines Mayo Clinic Compounding Communication

Sulfamethoxazole-trimethoprim interactions to avoid

The Checkup by Singlecare

JANUARY 9, 2024

While quite effective, methotrexate therapy must be closely monitored due to toxicities, according to the Food and Drug Administration (FDA). Avoiding them comes down to direct communication with your healthcare providers.

Adverse Reactions

Adverse Reactions Mayo Clinic Labelling FDA

9 home remedies for sinus infections

The Checkup by Singlecare

NOVEMBER 9, 2023

Sources Acute sinusitis , Medscape (2023) Sinus infections , Penn Medicine (2022) Sinus infections , Centers for Disease Prevention and Control (2019) Nasal irrigation to treat acute bacterial rhinosinusitis , American Family Physician (2005) How to perform nasal irrigation , UpToDate (2023) Is Rinsing Your Sinuses With Neti Pots Safe? ,

Immunization

Immunization Mayo Clinic Hospitals Communication

What causes sharp pain on the right side of the body?

The Checkup by Singlecare

NOVEMBER 13, 2023

To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. Asthma About 27 million people in the United States have asthma , which is equivalent to 1 in 12 people, according to the Asthma and Allergy Foundation of America.

Mayo Clinic

Mayo Clinic Vaccines Chemotherapy Communication

Sertraline interactions to avoid

The Checkup by Singlecare

OCTOBER 30, 2023

Sertraline carries multiple Food and Drug Administration (FDA) approvals, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder, posttraumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder.

Mayo Clinic

Mayo Clinic Communication Labelling FDA

Ondansetron interactions to avoid

The Checkup by Singlecare

JANUARY 12, 2024

Therefore, any onset of symptoms should be managed by immediate communication with a healthcare professional. Communicate directly with a healthcare professional anytime you require ondansetron so that a comprehensive review of interactions of both medications, diet, and conditions can occur to ensure a proper monitoring plan is put in place.

Mayo Clinic

Mayo Clinic Communication Dosage Chemotherapy

Testosterone side effects and how to avoid them

The Checkup by Singlecare

DECEMBER 26, 2023

Safety measures while using testosterone What are the FDA warnings about testosterone? The Food and Drug Administration (FDA) has multiple boxed warnings for testosterone therapy. The FDA has classified testosterone drugs as Schedule III controlled substances because of their potential for abuse and dependency.

FDA

FDA Dosage Mayo Clinic Controlled Substances

Disease of the Month - Amyotrophic Lateral Sclerosis (ALS)

PharmaShots

MAY 11, 2023

The thickened liquid form (Tiglutik) or the tablet (Exservan) Edaravone (Radicava) is administered intravenously and has been shown to slow the decline in the clinical assessment of daily functioning in people with ALS. Cleveland Clinic 3. Mayo clinic 4. Reference: 1. Science Direct 5. GlobeNewswire 6.

Mayo Clinic

Mayo Clinic Compounding Communication FDA

Tenaya’s cardiomyopathy gene therapy gets fast track boost

Pharmaceutical Technology

MAY 3, 2023

The US Food and Drug Administration (FDA) has granted Tenaya Therapeutics’ gene therapy TN-201 a fast track designation for the treatment of myosin binding protein C3 (MYBPC3)-associated hypertrophic cardiomyopathy (HCM). In January 2023, Tenaya announced FDA clearance for its Investigational New Drug (IND) application for TN-201.

Mayo Clinic

Mayo Clinic FDA Labelling Communication

Pharmacy Technician Pulse

Industry group says FDA botched COVID-19 convalescent plasma guidance

Imodium interactions to avoid

Trending Sources

Citalopram interactions to avoid

Hydroxyzine interactions to avoid

Methylprednisolone interactions to avoid

Nitrofurantoin interactions to avoid

Sulfamethoxazole-trimethoprim interactions to avoid

9 home remedies for sinus infections

What causes sharp pain on the right side of the body?

Sertraline interactions to avoid

Ondansetron interactions to avoid

Testosterone side effects and how to avoid them

Disease of the Month - Amyotrophic Lateral Sclerosis (ALS)

Tenaya’s cardiomyopathy gene therapy gets fast track boost

Stay Connected